$IEHC

Offerman Gail sold $64K of IEHC

Offerman Gail sold 2,000 shares of IEH Corp (IEHC) at $32.25 on 2026-08-13.

Original reporting
SEC EDGAR · Offerman Gail
Published Aug 17, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IEHC
Neutral
low confidence
Mentioned
$IEHC
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IEHCNeutralLow
01

Why it matters

A 10% owner sold 2,000 shares at $32.25 on 2026-08-13; the filing does not mention a pre-arranged 10b5-1 plan.

02

Market read

This provides incremental sentiment information via insider selling, but it is not a fundamental or event-driven catalyst.

03

What to watch

Insider sales often do not correlate with near-term fundamentals; traders should look for follow-on filings (additional sales, purchases) and any concurrent company-specific news.

Relevance 3/10Novelty 3/10Timing: filed 2026-08-17, sale dated 2026-08-13

Background

The article is an SEC Form 4 insider transaction disclosure for IEH Corp (IEHC).

Company-level read

Ticker impact

$IEHCNeutralLow confidence
Context

Form 4 shows 10% owner Offerman Gail sold 2,000 shares of IEH Corp on 2026-08-13 at $32.25 for about $64.5K.

Expected impact

Likely limited near-term impact; any effect is sentiment-driven and should fade unless more selling or new fundamentals emerge.

Evidence & confidence

The filing is a routine insider transaction disclosure. The article provides size ($64.5K) and sale details but no accompanying company news, guidance, or legal/regulatory event.

Market effects

None indicated; the disclosure is company-specific and small in dollar terms.

None indicated.

None indicated.

Counterpoint

The absence of a stated 10b5-1 plan could be interpreted as discretionary selling, but the transaction size is small and may reflect diversification or personal liquidity needs.

Key entities

  • IEH Corp

    Subject of the Form 4 insider sale by a 10% owner.

  • Offerman Gail

    Reporter of the Form 4 transaction, identified as a 10% owner.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).